Egypt Osteoporosis Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Egypt
  • Report ID : 4786

  • Format: PPT, PDF

Egypt Osteoporosis Drug Market: Segmented by Drug Class (Bisphosphonates, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator, Strontium Ranelate, Calcitonin, PTH Analog, Rank Ligand Inhibitor), Route of Administration (Oral, Injectables), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact, Growth, Trends, And Forecasts (2019 – 2028)

Published Date: June, 2021

Clear
SKU: 4786 Categories: ,

Egypt’s Osteoporosis drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

The International Osteoporosis Foundation reported that osteoporosis is a serious disease in the Middle East. It causes the bones to weaken, and they may break easily, become brittle or even develop cancer and infections.

The prevalence of osteoporosis is relatively high amongst the Egyptian population and is associated with a wide range of risk factors and medical conditions. Reports show that 53.9% of postmenopausal women have osteopenia while 28.4% have osteoporosis. 21.9% of males aged 20-89 have osteoporosis. Among the primary concerns for the disease treatment market is low awareness among the population. Egyptian Guidelines for the Diagnosis and Management of Osteoporosis have been developed to optimize the use of the existing tools available for the early diagnosis of osteoporosis and to help general practitioners as well as specialists in screening persons with or without risk factors to avoid the occurrence of fractures, especially the first fracture.

Market Drivers

The prevalence of osteoporosis in Egypt has been rated at 28.4% in women and 21.9% in men, whereas 53.9% of women and 26% of men had osteopenia. In rural areas of Upper Egypt, the prevalence of osteoporosis in postmenopausal women was even higher reaching up to 47.8%.

Such high prevalence highlights the magnitude of the problem in terms of public health and adds to the scope of market growth for osteoporosis drugs in Egypt.

The two fastest-growing age groups in the country are the elderly (65+) and the near-elderly (60-64), whose numbers will increase by 2.8 and 2.3 times, respectively, by 2050, relative to what they are in 2020 and this is the age bracket most affected by Osteoporosis. High Sunlight keeps people inside and this again increases demand for treatment of bone-related disorders.

However, osteoporosis is not a national health priority in Egypt and even though guidelines have been developed, it is not endorsed by the government of the country. There is absolutely no reimbursement policy for therapy and treatments due to which people must pay. These factors bring resistance to the market growth for the disease.

1. Osteoporosis Drug Market Overview…………………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………….
A. Rise in Prevalence of Osteoporosis in Egypt
B. Rapidly Rising Geriatric Population in Egypt
3. Major Types of Treatment
A. Hormone replacement therapy
B. Drugs
C. Diet Modifications
D. Exercise
E. Others
4. Osteoporosis Drug Market Segmentation…………………………………
A. Drug Class
I. Bisphosphonates
II. Hormone Replacement Therapy
III. Selective Estrogen Receptor Modulator
IV. Strontium Ranelate
V. Calcitonin
VI. PTH Analog
VII. Rank Ligand Inhibitor
B. Route of Administration
I. Oral
II. Injections
C. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Osteoporosis Major Drugs Market Share…………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………..
A. Pharco Pharmaceuticals Company overview, Product & Services, Strategies & Financials
B. EIPICO. Company overview, Product & Services, Strategies & Financials
C. EVA Pharma, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………….
A. New Trends and Development of Osteoporosis drug market
B. Future Opportunities
10. Conclusion

By Drug class

The market for the treatment of osteoporosis has been segmented into Bisphosphonates, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator, Strontium Ranelate, Calcitonin, PTH Analog, Rank Ligand Inhibitor

By Route of Administration

By route of administration, the drug market can be segmented into oral and injectables.

By Distribution Channel

By distribution channel, the osteoporosis drug market can be segmented into hospital pharmacies, online pharmacies, and retail pharmacies

Major Players

Egypt’s Osteoporosis drug market appears to be fragmented and with the presence of several local and global companies including Novartis, GSK, Sanofi, MSD, Pharco, Amoun, EIPICO, Eva Pharma, Pfizer, Hikma. These companies occupied the largest share in Egypt’s pharmaceutical market as of 2019.

Merck Sharp & Dohme (MSD Egypt) is established in Egypt as a Scientific Office in 1960. From 1960 until 1984, MSD products have either been imported through a public sector distribution company (EGYDRUG) or locally manufactured through a government-owned manufacturer (Al-Kahira Company) and a private sector company (EIPICO). It reached several milestones in the Egyptian market including Alendronate, the 1st non-hormonal therapy for osteoporosis with proven fracture reduction.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements